Background Diseases caused by Streptococcus pneumoniae (S. pneumoniae) continue to
cause substantial morbidity and mortality globally. Whilst pneumococcal polysaccharide …

Two pneumococcal vaccines currently exist and have been recommended for the prevention
of pneumococcal infection in adults 65 years of age and older: the 23-valent polysaccharide …

Clin Microbiol Infect 2011; 17 (Suppl. 6): E1–E59 Abstract This document is an update of
Guidelines published in 2005 and now includes scientific publications through to May 2010 …

BACKGROUND: Patients with Chronic Obstructive Pulmonary Disease (COPD) are at higher
risk of developing Community-Acquired Pneumonia (CAP) than patients in the general …

3. Chest radiograph should be repeated if the patient is not improving and also for all those
patients who have persistence or worsening of symptoms/physical signs or those in whom …

Pneumococcal polysaccharide vaccine has been licensed for use in the United States for>
30 years, and two-thirds of the elderly population in the United States have received this …

Vaccination is the only public-health measure likely to reduce the burden of pneumococcal
diseases. In 2010, a group of European experts reviewed evidence on the burden of …

OBJECTIVES: To investigate the risk of hospitalization for pneumonia in older adults in
relation to biophysical environmental factors. DESIGN: Population‐based case control study …

Community-acquired pneumonia is common and important infectious disease in adults. This
work represents an update to 2009 treatment guideline for community-acquired pneumonia …

For the influenza pandemic of 2009–2010, countries responded to the direct threat of
influenza but may have missed opportunities and strategies to limit secondary …